论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
Authors Zhou L, Le Y, Tian J, Yang X, Jin R, Gai X, Sun Y
Received 7 October 2018
Accepted for publication 29 November 2018
Published 20 December 2018 Volume 2019:14 Pages 81—91
DOI https://doi.org/10.2147/COPD.S190023
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Amy Norman
Peer reviewer comments 3
Editor who approved publication: Professor Chunxue Bai
Background and purpose: Cigarette
smoke (CS) induces alveolar destruction through overproduction of proteinases
including matrix metalloproteinase (MMP)-9 by alveolar macrophages (AMs). Receptor
activator of nuclear factor-κB ligand (RANKL) functions in immune regulation
and cytokine secretion; whether it is involved in CS-induced MMP-9 expression
is unknown. The purpose of our study was to investigate the expression and
functional role of RANKL pathway in MMP-9 production pertaining to the
pathogenesis of COPD.
Materials and methods: We first
localized RANKL and its receptor RANK in the lungs of mice exposed to long-term
CS exposure. Next, we studied RANKL and RANK expression under CS extract (CSE)
stimulation in vitro. Lastly, we studied the in vitro biological function of
RANKL in CS-induced production of MMP-9.
Results: Both RANKL and
RANK were highly expressed in AMs in CS-exposed mice, but not in the control
mice. In vitro, CSE increased the expressions of RANKL and RANK in macrophages.
AMs responded to CSE and RANKL stimulation by overexpressing MMP-9, and
CSE-induced MMP-9 expression was partly blocked by using monoclonal anti-RANKL
antibody.
Conclusion: RANKL/RANK
pathway mediates CS-induced MMP-9 expression in AMs, suggesting a novel
mechanism for CS-associated emphysema.
Keywords: COPD, receptor
activator of nuclear factor-κB ligand, RANK, alveolar macrophages, MMP-9
